
Aphria Inc. APHA
Aphria Inc. P/S Ratio 2011-2026 | APHA
Annual P/S Ratio Aphria Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 2.04 | 7.18 | 40.6 | 20.9 | 8.23 | 68.3 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 68.3 | 2.04 | 24.5 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
ADMA Biologics
ADMA
|
7.41 | $ 16.45 | 0.43 % | $ 3.92 B | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
AbCellera Biologics
ABCL
|
12.8 | $ 3.64 | -1.89 % | $ 1.09 B | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.83 | 4.23 % | $ 4.53 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 8.4 | -1.81 % | $ 1.39 B | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
ANI Pharmaceuticals
ANIP
|
1.95 | $ 76.75 | 0.85 % | $ 1.48 B | ||
|
Apellis Pharmaceuticals
APLS
|
2.76 | $ 19.93 | -1.14 % | $ 2.51 B | ||
|
Applied Therapeutics
APLT
|
54.1 | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Athersys
ATHX
|
253 | - | 3.77 % | $ 22.4 M | ||
|
AVEO Pharmaceuticals
AVEO
|
2.32 | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
13.6 | $ 163.82 | -0.14 % | $ 8.15 B | ||
|
BridgeBio Pharma
BBIO
|
26.1 | $ 66.98 | 3.8 % | $ 12.8 B | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
5.55 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
1.49 | - | -7.31 % | $ 87 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
BioMarin Pharmaceutical
BMRN
|
3.63 | $ 60.75 | 3.79 % | $ 11.7 B | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
0.00137 | $ 3.24 | 1.73 % | $ 1.16 M | ||
|
Cabaletta Bio
CABA
|
50.3 M | $ 3.41 | 4.77 % | $ 3.98 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Capricor Therapeutics
CAPR
|
6.17 | $ 25.71 | -0.5 % | $ 688 M | ||
|
Agios Pharmaceuticals
AGIO
|
30.2 | $ 28.49 | 0.04 % | $ 1.65 B | ||
|
CymaBay Therapeutics
CBAY
|
110 | - | - | $ 3.45 B | ||
|
Avid Bioservices
CDMO
|
3.03 | - | - | $ 789 M |